CBIZ Investment Advisory Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.52K Sell
303
-1,336
-82% -$35.6K ﹤0.01% 173
2025
Q4
$40.8K Buy
1,639
+121
+8% +$3.05K ﹤0.01% 163
2025
Q3
$38.7K Sell
1,518
-744
-33% -$18.4K ﹤0.01% 154
2025
Q2
$54.8K Buy
2,262
+1,354
+149% +$31.6K ﹤0.01% 125
2025
Q1
$23K Buy
908
+403
+80% +$10.5K ﹤0.01% 212
2024
Q4
$13.4K Buy
505
+106
+27% +$2.88K ﹤0.01% 258
2024
Q3
$11.6K Buy
399
+31
+8% +$904 ﹤0.01% 253
2024
Q2
$10.3K Sell
368
-272
-43% -$7.49K ﹤0.01% 250
2024
Q1
$17.8K Buy
+640
New +$17.8K ﹤0.01% 199
2021
Q3
Hold
0
47
2021
Q2
Hold
0
43
2021
Q1
Hold
0
39
2020
Q4
Hold
0
35
2020
Q3
Hold
0
36
2020
Q2
Hold
0
51
2020
Q1
Hold
0
44
2019
Q4
Hold
0
54

Other funds holding PFE

CBIZ Investment Advisory Services's PFE Position: Q1 2026 in Review

CBIZ Investment Advisory Services reduced its Pfizer (PFE) stake by 82% in Q1 2026, selling an estimated $35.6K and leaving 303 shares worth $8.52K. The position accounts for ﹤0.01% of the portfolio, ranked #173.

CBIZ Investment Advisory Services first reported a position in PFE in Q1 2024 and has held it in 9 quarters since. The position peaked at $54.8K in Q2 2025. 2,933 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • CBIZ Investment Advisory Services held 303 shares of Pfizer worth $8.52K as of Q1 2026.
  • CBIZ Investment Advisory Services sold 1,336 Pfizer shares in Q1 2026, an estimated $35.6K.
  • Pfizer made up ﹤0.01% of CBIZ Investment Advisory Services's portfolio in Q1 2026, its #173 holding.
  • CBIZ Investment Advisory Services first reported a position in Pfizer in Q1 2024 and has held it in 9 quarters since.
  • CBIZ Investment Advisory Services's Pfizer position peaked at $54.8K in Q2 2025.
  • 2,933 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on CBIZ Investment Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.